Mrs. H is 74, with heart failure, diabetes and kidneys that do not like either. She is synthetic. Follow her from the ICU to the ward, through discharge, home, and past day 30. In each room the same reasoning layer reads what that room has, decides who should hear it, and carries the finding in the same mediator. Answer each finding, or let it go unanswered and watch it escalate. The trail on the right is one record from the first minute to the last.
Every step in every room, in order. The hospital keeps it through day 30. Each line is a FHIR AuditEvent.
Label sources: metformin, FDA Drug Safety Communication, 8 April 2016, revising the labels to contraindicate metformin when eGFR is below 30 mL/min/1.73 m². Ibuprofen and other NSAIDs: FDA Drug Safety Communication, 9 July 2015, strengthening the labels; the revised labeling states that NSAID use increases the risk of heart failure. Not a medical device. Not for clinical use.
Daniel Pettus spent forty years in medical device and health IT leadership at Alaris, CareFusion and BD, contributed to IHE Patient Care Device interoperability standards, and is named on two United States patents. He writes Inside the Loop at insidetheloopdp.substack.com and is the author of The Technology Was Never the Problem, at pettusbook.com.
AI MedAgent is a research demonstration of a patent-pending method. Advisory only. Not a medical device. Not for clinical use. Synthetic data only.